R, P. d. L., A, K., S, I., SR, T., R, C., M, G., . . . AM, R. (2022). Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia. The New England journal of medicine, 386(1), 11. https://doi.org/10.1056/NEJMoa2109965
Chicago Style (17th ed.) CitationR, Peffault de Latour, et al. "Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia." The New England Journal of Medicine 386, no. 1 (2022): 11. https://doi.org/10.1056/NEJMoa2109965.
MLA (9th ed.) CitationR, Peffault de Latour, et al. "Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia." The New England Journal of Medicine, vol. 386, no. 1, 2022, p. 11, https://doi.org/10.1056/NEJMoa2109965.
Warning: These citations may not always be 100% accurate.